Small-molecule-induced Rho-inhibition: NSAIDs after spinal cord injury

Marcel A. Kopp(Charité - Universitätsmedizin Berlin), Jan M. Schwab(The Ohio State University Wexner Medical Center), Thomas Liebscher, Stefan Laufer(University of Tübingen), Ulrich Dirnagl(German Center for Neurodegenerative Diseases), Benedikt Brommer(CellAct Pharma (Germany)), Andreas Niedeggen(Diagnostic and Treatment Centre Berlin), Gerhard J. Jungehülsing(Heidelberg University), Stephen M. Strittmatter(Yale University)
Cell and Tissue Research
February 20, 2012
10.1007/s00441-012-1334-7
Cited by 77

Related Papers

Resolvin E1 and protectin D1 activate inflammation-resolution programmes
|Nature|2007|1.2k
Central nervous system injury-induced immune deficiency syndrome
|Nature reviews. Neuroscience|2005|948
Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use
|The Lancet Neurology|2009|581
N‐methyl‐<scp>D</scp>‐aspartate receptor antibodies in herpes simplex encephalitis
|Annals of Neurology|2012|414
Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein
|Journal of Neuroscience|2010|406